E85.89
Other amyloidosis
Clinical Classification Guidelines
Medical Intelligence & Overview
Other amyloidosis, classified under ICD-10 code E85.89, refers to a group of rare conditions characterized by the abnormal buildup of amyloid proteins in various tissues and organs of the body. Amyloid deposits can interfere with normal organ function, leading to a range of health issues. Unlike more common forms of amyloidosis, such as AL or AA types, other amyloidosis encompasses less typical variations and causes that are not categorized elsewhere.
Causes & Symptoms
Clinical Causes: Misfolded protein production due to rare genetic mutations Chronic inflammatory diseases leading to abnormal protein deposits Certain types of cancers that produce amyloid proteins Dialysis-related amyloidosis resulting from long-term kidney dialysis Localized amyloid deposits with no systemic involvement Unknown or idiopathic cases where the exact cause is unclear
Key Symptoms: Swelling or enlargement of affected organs Unexplained fatigue or weakness Shortness of breath due to heart or lung involvement Numbness, tingling, or weakness in limbs from nerve involvement Difficulty swallowing or changes in voice if throat tissues are affected Skin changes such as lumps or waxy patches Digestive issues like nausea, constipation, or weight loss
Diagnostic & Treatment
Diagnosis Path: Tissue biopsies to identify amyloid deposits using Congo red staining under microscopy Imaging tests such as echocardiograms or MRI to assess organ damage Blood and urine tests to detect abnormal proteins Serum amyloid P component scans to locate and quantify amyloid deposits Genetic testing if a hereditary form is suspected
Treatment Protocols: Medications to stabilize existing proteins or reduce amyloid production Chemotherapy or targeted therapies if an underlying plasma cell disorder is identified Organ-specific supportive care such as diuretics for heart failure or therapy for nerve pain Dialysis adjustments or alternative therapies in dialysis-related cases Experimental treatments and participation in clinical trials Regular monitoring of organ function to assess disease progression
Clinical Advice & FAQs
Billing Guidance
Is E85.89 a billable ICD-10 code?
Yes, E85.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E85.89?
Clinical documentation must specify the nature of Other amyloidosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference